3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
38
Stomach Neoplasms
8
Neoplasm Metastasis
7
Colorectal Neoplasms
6
Neoplasms
5
HER2-positive Breast Cancer
5
Esophageal Neoplasms
5
Lung Neoplasms
4
Endometrial Neoplasms
4
Carcinoma, Non-Small-Cell Lung
4
Rectal Neoplasms
3
Ovarian Neoplasms
3
Multiple Myeloma
3
Adenocarcinoma
3
Triple Negative Breast Neoplasms
2
Squamous Cell Carcinoma of Head and Neck
2
Salivary Gland Neoplasms
2
Prostatic Neoplasms
2
Pancreatic Neoplasms
2
Lymphoma, Non-Hodgkin
2
Colonic Neoplasms
2
Brain Neoplasms
2
Biliary Tract Neoplasms
2
Anatomic Stage II Breast Cancer AJCC v8
2
Anatomic Stage I Breast Cancer AJCC v8
2
Adenocarcinoma Of Esophagus
2
Uterine Neoplasms
1
Uterine Cervical Neoplasms
1
Urinary Bladder Neoplasms
1
Thyroid Neoplasms
1
Interventions
Doxorubicin
14
pembrolizumab
11
Specimen Handling
11
Magnetic Resonance Spectroscopy
10
Biopsy
9
Cyclophosphamide
8
X-Rays
7
Radiotherapy
7
Nivolumab
7
Ifosfamide
7
Phantoms, Imaging
6
Gemcitabine
6
liposomal doxorubicin
5
Temozolomide
5
Radiation
5
tazemetostat
4
palbociclib
4
Trabectedin
4
Nuclear Medicine Department, Hospital
4
Irinotecan
4
Ipilimumab
4
pazopanib
3
larotrectinib
3
fludarabine
3
cabozantinib
3
atezolizumab
3
Surveys and Questionnaires
3
Radiation Dose Hypofractionation
3
Proton Therapy
3
Carboplatin
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Sarcoma
×
Trastuzumab
×
90 days
×
Clear all
No trials found.